All Publications

Back to Trudo Lemmens's profile

Books

Trudo Lemmens, Jennifer Bergman, Kanksha Mahadevia Ghimire and Myriam Shahid, Medical Law in Canada (Alphen aan den Rijn: Wolters Kluwer, 2020).

Reading the Future?: Legal and Ethical Challenges of Predictive Genetic Testing (with M. Lacroix & R. Mykitiuk; with a contribution by Lisa Austin & Bita Amani) (Cowansville: Les Éditions Thémis, 2007).

Trudo Lemmens, Andrew Flavelle Martin, Ian Lee & Cheryl Milne (eds), Regulating Creation: Ethics, Law and Policy of Assisted Human Reproduction (University of Toronto Press, 2016).

Trudo Lemmens & Duff R. Waring (eds), Law and Ethics in Biomedical Research:  Regulation, Conflict of Interest, and Liability,   (Toronto: University of Toronto Press, 2006).

Book Chapters

Trudo Lemmens, Mary Shariff, Leonie Herx, “L’Aide Médicale à Mourir et le sacrifice de la norme de qualité de soins dans la pratique médicale » in Nathalie Vézina, Pascal Fréchette and Louise Bernier, Mélanges Robert P. Kouri – L’humain au cœur du droit  (Yvons Blais : 2021) at 621-644.

Trudo Lemmens & Gregory Ringkamp, “The Declaration of Helsinki and Transparency: When International Ethics Standards Face National Implementation Challenges” in Ulf Schmidt, Andreas Frewer & Dominique Sprumont, (eds.), Research Ethics and the Declaration of Helsinki (Oxford University Press, 2020) 284-309.

Trudo Lemmens & Elizabeth Kurz, “The Future of Medically-Hastened Death in Canada: Why and How We Should Avoid the Mortal Flaws of Belgium’s Euthanasia Regime” in Mark Henaghan & Jesse Wall, Law, Ethics, and Medicine: Essays in Honour of Peter Skegg (Wellington: Thompson Reuters, 2016) 96-122 (chapter based on T. Lemmens, “The Conflict Between Open-Ended Access.” (see infra)

“The Commodification of Gametes: Why Prohibiting Untrammeled Commercialization Matters” in Trudo Lemmens, Andrew Flavelle Martin, Ian Lee & Cheryl Milne (eds), Regulating Creation: Ethics, Law and Policy of Assisted Human Reproduction (University of Toronto Press, 2016) 415-460

Trudo Lemmens & C. Tess Sheldon, “The Governance of the Safety and Efficacy of Psychopharmaceuticals: Challenges and Opportunities for Reform” in J. Chandler & Colleen Flood, eds, Law and Mind: Mental Health Law and Policy in Canada (LexisNexis 2016) 223-251

“The Conflict Between Open-ended Access to Physician-Assisted Dying and The Protection of the Vulnerable: Lessons from Belgium’s Euthanasia Regime in the Post-Carter Era” in Catherine Régis, Lara Khoury, Robert Kouri, “Les Grands Conflits en Droit de la Santé” (Cowensville: Yvon Blais, 2016) 261-317

"Informed Consent" in Yann Joly & Bartha M. Knoppers (eds), Routledge Handbook of Medical Law and Ethics (Routledge 2015) 27-51.

“L’accès à l’information et le droit à la santé : La transparence des essais cliniques comme une obligation dans le contexte des droits de l’Homme (Access to Information and the Right to Health: Transparency of Clinical Trials as a Human Rights Obligation)”  (July 1, 2012). Louise Lalonde, ed., Le droit, vecteur de la gouvernance en santé? Défis théoriques et enjeux pratiques de l’accès aux soins de la santé (with Candice Telfer) (Sherbrooke: Éditions Revue de Droit de L'Université De Sherbrooke, 2012) pp. 131-167.

“Clinical Trials Transparency and the Right to Health” (with Candice Telfer) in I. Glenn Cohen, ed., The Globalization of Health Care (Cambridge Mass.: Oxford University Press, 2012).

"Talk to Her, or Breaking the Silence of Neglected Bonds" in Sean Caulfield, Curtis Gillespie & Timothy Caulfields, eds, Perceptions of Promise: Biotechnology, Society and Art (Seattle: University of Washington Press, 2011) 9-13. 

"Insurance and Genetic Information" (with Yvonne Bombard) in Encyclopedia of Life Science (John Wiley & Sons: Chisester, 2010) pp. 1-6.

"The End of Individual Control Over Health Information: Governing Biobanks and Promoting Fair Information Practices" (with Lisa Austin) in Jane Kaye and Mark Stranger, Governing Biobacks (Farnham (UK): Ashgate, 2009) 243-266.

"Privacy, Consent, and Governance" in Kris Dierickx & Pascal Borry, New Challenges for Biobanks: Ethics, Law and Governance (Antwerpen: Intersentia, 2009) 111-122.

"Les conflits d'intérêts dans la recherche biomédicale" in Oliver Guillod ed., Conflits d'intérêts dans le système de santé : 15e Journée de droit de la santé (Neuchâtel: Institut de droit de la santé, Université de Neuchâtel, 2009) 223-248.

"Biobanken en nieuw genetisch onderzoek: een utidaging voor de bescherming van de privacy van medische gegevens" in Jan Wouters and Cedric Ryngaert, eds., Mensenrechten: Actuele Brandputen (Leuven: Acco, 2008) 135-156.

"The Plasticized Pregnant Woman and Legal Rights over Reproductive 'Material'" in Timothy Caulfield & Shawn Caulfield, Imagining Science (Edmonton: University of Alberta Press, 2008).

"Genetic Information Access, a Legal Perspective: A Duty to Know or a Right Not to Know, and a Duty or Option to Warn?" (with Lori Luther & Michael Hoy) Encyclopedia of Life Sciences (John Willey & Sons, 2008).

"The Challenges of Genetic Information" (with Lisa Austin) in Horst W. Doelle & Edgar J. DaSilva, eds., Biotechnology, in Encyclopedia of Life Support Systems (EOLSS). Developed under the auspices of the UNESCO, Eolss Publishers, Oxford, UK.

Republication of discussion paper written for the Canadian Biotechnology Advisory Committee; also published in shorter form as article in ISUMA, see further.

"Institutional Conflicts of Interest" peer-reviewed chapter for on-line teaching manual, Charles Weijer & David McKnight, eds., Biotheics Education program, Royal Society of Physicians and Surgeons (2008). http://rcpsc.medical.org/bioethics/cases/index.php

"Canadese regelgeving inzake medischer keuringen voor verzekerigen" [Canadian regulatiosn related to medical testing for insurance purposes] in H. Nys, H. Cousy, T. Lemmens & C. Van Schoubroeck (eds.), Contactforum "Medische keuring bij private verzekeringen juridisch doorgelicht" 22 Maart 2007 (Brussel: Royal Flemish Academy of Belgium for Science adn the Arts, 2008).

"The subjectivity of objectivity: the social, cultural and political shaping of evidence-based medicine" (with Raymond Devries & Charles Bosk) in Belinda Bennett, Terry Carney and Isabel Karpin, eds., The Brave New World of Health (Sydney: Federation Press, 2008)

"Conflicts of Interest of Clinician-Researchers" (with Lori Luther) in Peter S. Singer & Adrian Viens, eds., Cambridge Textbook of Bioethics (Cambridge: Cambridge University Press, 2008). 

"Conflict of Interest in Medical Research: Historical Developments" in Ezekiel E. Emanuel et al., eds., The Oxford Textbook of Clinical Research Ethics (Oxford University Press, 2008). 

"Mandatory Clinical Trial Registration: Rebuilding Trust in Medical Research" (with Ron Bouchard) in Global Forum for Health Research, Global Forum Update on Research for Health, Volume 4: Equitable Access: Research Challenges for Health in Developing Countries (London: Pro-Book Publishing, 2007) 40.

Forthcoming also in translation in Portuguese in: Bioética, published by the Conselho Federal de Medicina (Brazilian Federal Medical Council).

"Human Genetic Data Banks: From Consent to Commercialization - An Overview of Current Concerns and Conundrums" (with Lori Luther) in Horst W. Doelle & Edgar J. DaSilva, eds., Biotechnology, in Encyclopedia of Life Support Systems (EOLSS). Developed under the auspices of the UNESCO, Eolss Publishers, Oxford, UK.

"Regulation of Pharmaceuticals in Canada" with R.A. Bouchard, in Canadian Health Law and Policy, 3rd ed., J. Downie, T. Caulfield & C. Flood eds. (Toronto: Butterworths, 2007) 311.

"Insurance and Human Rights: What Can Europe Learn From Canadian Discrimination Law?" (with Yves Thiery) in Herman Cousy, et al., eds., Discrimination in Insurance (Antwerp: MAKLU, 2007).

"The Helsinki Declaration and the Law: an International and Comparative Analysis" (with Dominique Sprumont & Sara Girardin) in Andreas Frewer & Ulf Schmidt, eds., History and Theory of Human Experimentation. The Declaration of Helsinki and Modern Medical Ethics (Stuttgart: Franz Steiner Verlag, 2007) 223.

"The Human Subjects Trade: Ethical, Legal, and Regulatory Remedies to Deal with Recruitment Incentives and to Protect Scientific Integrity" (with Paul B. Miller) in Law and Ethics in Biomedical Research: Regulation, Conflict of Interest & Liability (Toronto: University of Toronto Press, 2006) 132.

"Commercialized Medical Research and the Need for Regulatory Reform" in C. Flood, ed., Just Medicare: What's In, What's Out, Who Decides (Toronto: University of Toronto Press, 2006) 396.

Also published in the ICFAI Journal of Healthcare Law 2007 (see further) and reprinted as a chapter in Legal Implications of Clinical Research (Panjagutta: Amicus Book & ICFAI University Press) [forthcoming in 2008]. 

"The CMA's Chaoulli Motion and the Myth of Promoting Fair Access to Health Care" (with Tom Archibald) in C. Flood, K. Roach & L. Sossin, eds., Access to Care, Access to Justice (University of Toronto Press, 2005) 323.

"Integrating Values in Risk Analysis of Biomedical Research: The Case for Regulatory and Law Reform" (with Duff R. Waring) in Law Commission of Canada, ed., Law and Risk (Vancouver: University of British Columbia Press, 2005) 156. (view abstract)

"Intégration des valeurs dans l'évaluation du risqué lié à la recherche biomédicale: arguments en faveur d'une réforme de la réglementation et du droit" dans Commission du Droit du Canada, ed., Le Droit et Le Risque: Mémoires du concours perspectives juridiques 2003 (Saint-Nicolas, Québec: Les Presses de l'Université Laval, 2006) 233.

"Les conflits d'intérêts dans le temple de la science médicale: diagnostic et options thérapeutiques" in Ysolde Gendreau, ed., Dessiner la société par le droit/Mapping Society Through Law (Montréal: Les Éditions Thémis, 2004) 77-115.

"Insurance and Human Genetics: Approaches to Regulation" in David N. Cooper, ed., Nature Encyclopedia of the Human Genome (Houndmills, Basingstoke, Hampshire, Eng.: Macmillan, 2003) 495.

"Contrôler les conflits d'intérêts dans le temple de la science" in D. Sprumont & M. Trutmann, eds., La recherche avec les cellules souches : un défi! Mais pour qui? Rapport IDS Nr.3  (Genève: Georg, 2003)  7.

"Voorafgaande Wilsverklaringen in Canada: Evenwichtsoefeningen Tussen Autonomie, Bescherming van de Patiënt en Andere Maatschappelijke Belangen" [Advance Directives in Canada: Balancing Autonomy, Protection of Patients, and Other Social Interests] in Belgisch Raadgevend Comite voor Bio-Ethiek, A. van Orshoven & Y. Englert, eds., "Levenstestament" en Andere Voorafgaande wilsverklaringen: [The "Living Will" and Other Advance Directives] (Antwerp: Garant, 2003) 121.

"Déclarations préalable de volonté au Canada: exercice de haute voltige entre autonomie, protection du patient et autres intérêts de la societé" in Comité Consultatif de Bioethique, ed., "Testaments de vie" et autres directives anticipées (Louvain-la-Neuve: Deboeck & Larcier, 2003) 108. [French translation of foregoing article]

"Ethics Review for Sale?  Conflict of Interest and Commercial Research Review Boards" (with Benjamin Freedman) in George F. Tomossy & David N. Weisstub, eds., Human Experimentation and Research(Aldershot, Eng.: Ashgate, 2003) [republication].

"Showing Respect for the Dead: Fair Compensation for Research Autopsies in Malawi" (with R. Nwabueze) in James V. Lavery, Elizabeth Wahl, Christine Grady & Ezekiel J. Emanuel, eds., Case Studies in International Research Ethics (New York: Oxford University Press, 2007) 287.

"Research Involving Humans" (with K.C. Glass) in J. Downie, T. Caulfield & C. Flood, eds., Canadian Health Law and Policy, 2nd ed. (Toronto: Butterworths, 2002) 459.

"Sports, Doping and Clashing Values" in D. Panagiotopoulos, ed., Ethics on Sport [Proceedings of the 2nd International Congress on Sports Law held in Olympia, Greece, 29-31 October 1993] (Athens: Hellin, 2000) [republication].

"Conflict of Interest and the Commercialization of Biomedical Research: What is the Role of Research Ethics Review?"  (with K.C. Glass) in T. Caulfield & B. Williams-Jones, eds., The Commercialization of Genetic Research: Ethical, Legal and Policy Issues (New York: Plenum Press, 1999) 79.

"Private Parties, Public Duties? The Shifting Role of Insurance in the Genetics Era" in A. Thompson & R. Chadwick, eds., Genetic Information: Acquisition, Access, and Control (New York: Plenum Press, 1999) 31.

"Genetics in Life, Disability and Additional Health Insurance in Canada: A Comparative Legal and Ethical Analysis" (with P. Bahamin) in B. Knoppers, ed., Socio-Ethical Issues in Human Genetics (Cowansville, Quebec: Yvon Blais, 1998) 108.

"Harm Reduction and Doping: The Clashing Values of Athletic Sports" in P. Erickson et al., eds., New Public Health Policies and Programs for the Reduction of Drug Related Harms (Toronto: University of Toronto Press, 1997) 131.

"Towards the right to be killed? Treatment refusal, assisted suicide and euthanasia in the United States and Canada" in G. Dunstan et al., eds., Euthanasia, Death, Dying and the Medical Duty (1996) 52(2) British Medical Bulletin 341.

"Internationale Koop" [International Sales] (with H. Van Houtte) in G. Schrans & H. Van Houtte, eds., Internationaal Handels- en Financieel Recht [International Trade and Financial Law] (Leuven: Acco, 1991) 256.   
 

Articles (peer-reviewed; law review articles; invited contributions)

Sonu Gaind, Trudo Lemmens, Ramona Coelho, John Maher, “Canada's Medically Administered Death (MAD) Expansion for Mental Illness: Targeting the Most Vulnerable” (2022) 70(4) World Medical Journal 72-82.

Ramona Coelho, Sonu Gaind, Trudo Lemmens, John Maher, “Normalizing Death as "Treatment" in Canada: Whose Suicides do we Prevent, and whose do we Abet?” (2022) 70(3) World Medical Journal 27-35 (online: https://www.wma.net/wp-content/uploads/2022/11/WMJ_2022_03_final-1.pdf)

Emily Baron & Trudo Lemmens, “Privacy and Health in Canada” in Thierry Vansweevelt & Nicola Glover-Thomas, Privacy and Health, World Association Medical Law (forthcoming) (with Emily Baron).

Sera Whitelaw, Trudo Lemmens & Harriette Van Spal, “The Expansion of Medical Assistance in Dying in the COVID-19 Pandemic Era and Beyond: Implications on the Vulnerable (Accepted for publication in Canadian Journal of General Internal Medicine.)

Ramona Culhoe, John Maher, Trudo Lemmens & Sonu Gaind, “Missing the Mark on a Profound Social Change with MAID for Mental Illness” Policy Options (March 24, 2022), https://policyoptions.irpp.org/magazines/missing-the-mark-on-a-profound-social-change-with-maid-for-mental-illness/

Trudo Lemmens, How the Mantra of Informed Consent in the Canadian Assisted Dying Debate Obscures Somatic Oppression, JOTWELL (September 8, 2021), https://health.jotwell.com/how-the-mantra-of-informed-consent-in-the-canadian-assisted-dying-debate-obscures-somatic-oppression/.

Joel Lexchin, Janice Graham, Matthew Herder, Tom Jefferson & Trudo Lemmens, “Regulators, Pivotal Clinical Trials, and Drug Regulation in the Age of Covid-19” (2020) 51(1) International Journal of Health Services at 5-13.

Trudo Lemmens, “Addressing the Tension between Discrimination Law and Pandemic Clinical Triage Protocols” (reviewing Samuel R. Bagenstos, “May Hospitals Withhold Ventilators from COVID-19 Patients with Pre-Existing Disabilities?” 130 Yale Law Journal Forum (forthcoming 2020); and Deborah Hellman & Kate Nicholson, “Rationing and Disability in a State of Crisis”, No. 2020-33 Virginia Public Law and Legal Theory Research Paper (6 April 2020)) JOTWELL (August 2020) https://health.jotwell.com/addressing-the-tension-between-discrimination-law-and-pandemic-clinical-triage-protocols/

Trudo Lemmens & Roxanne Mykitiuk, “Disability Rights Concerns and Clinical Triage Protocol Development During the COVID-19 Pandemic” (2020) 40:4 Health Law in Canada at 103-112.

Trudo Lemmens, “When a Theoretical Commitment to Broad Physician Aid-in-Dying Faces the Reality of Its Implementation” (2019) 19(10) American Journal of Bioethics 65-68, online: https://doi.org/10.1080/15265161.2019.1654026.

Trudo Lemmens & Kanksha Mahadevia Ghimire, “Regulation of the Health Professions in Ontario: Self-Regulation with Statutory-Based Public Accountability” (2019) 19(3) Journal of Health Law/Revista de Dereito Sanitario at 124-204.

Maria Eugenio Brunella & Trudo Lemmens, “Editorial: Interdisciplinary Reflections on Regulating Creation and the Assisted Human Reproduction Act: A Special Volume” (2019) 39(4) Health Law in Canada at 42-48.

Trudo Lemmens & Carlos Herrera Vacaflor, “Research Transparency in the Americas: The Need to Coordinate Regulatory Spheres” (2018) 362 British Medical Journal k2493-8.

Trudo Lemmens, “Charter Scrutiny of Canada's Medical Assistance in Dying Law and the Shifting Landscape of Belgian and Dutch Euthanasia Practice” (2018) 85 Supreme Court Law Review (2nd)at 453-539.

Trudo Lemmens, Medical Assistance in Dying Laws and the Therapeutic Relevance of Hope in the Mental Health Context, JOTWELL (28 May 2018) (reviewing Thomas Blikshavn, Tonje Lossius Husum, and Morten Magelssen, Four Reasons Why Assisted Dying Should Not Be Offered for Depression, 14 J. of Bioeth. Inq. 151-157 (2017), online: https://health.jotwell.com/medical-assistance-in-dying-laws-and-the-therapeutic-relevance-of-hope-in-the-mental-health-context/.

Trudo Lemmens, Heesoo Kim & Elizabeth Kurz, “Why Canada’s Medical Assistance in Dying Law Should be C(h)arter Compliant and What it May Help to Avoid” (2017) 11(1) McGill Journal of Law & Health S61-S148.

Renata Axler, Fiona A. Miller, Pascale Lehoux & Trudo Lemmens, “The Institutional Workers of Biomedical Science: Legitimizing Academic Entrepreneurship and Obscuring Conflicts of Interest” (2017) 12(5) Science & Public Policy at 310-325. 
Annie Wang, Trudo Lemmens & Nav Persaud, “Medication Access Via Hospital Admission” (2017) 63(5) Canadian Family Physician at 344-347. 

Shannon Gibson, Renata Axler & Trudo Lemmens, “Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research” (2017) 12(5) Journal of Empirical Research on Human Research Ethics at 310-325. 

“Decision-Making Capacity to Consent for Medical Assistance in Dying for Persons with Mental Disorders” (with Louis Charland & Kyoko Wada) (2016) Open Issue Journal of Ethics in Mental Health 1-15.

“Should assisted dying for psychiatric disorders be legalized in Canada?" (with Scott Y.H. Kim) (2016) Canadian Medical Association Journal cmaj.160365; doi:10.1503/cmaj.160365.

“Why the Shift? Taking a Closer Look at the Growing Interest in Niche Markets and Personalized Medicine” (with Shannon Gibson, Hamid Raziee) (2015) 7(1) World Medical & Health Policy 3-27.

"Decreasing the Data Deficit: Improving Post-Market Surveillance in Pharmaceutical Regulation" (with Shannon Gibson) (2015) 59(4) McGill Law Journal 943-988 

“The Promise and Peril of Adapting the Regulatoy System to the Pharmacogenomic Context” (with Shannon Gibson) (2015) 8(2) McGill Journal of Law & Health S145-230.

"Niche Markets and Evidence Assessment in Transition: A Critical Review of Proposed Drug Reforms" (with Shannon Gibson) (2014) 22(2) Medical Law Review 200-220

“The Markingson Case and the Ethics of Institutional Proceduralism,” in Trudo Lemmens and Bernadette J. Richards, Recent Developments: Investigating research and Accessing Reproductive Material (2014) 11(1) Bioethical Inquiry 11-16. 

“Consent for Nondiagnostic Research Biopsies: A Pilot Study of Participant Recall and Therapeutic Orientation” (with Roberto Abadie, Jonathan Kimmelman and Josiane Lafleur) (2014) 36(3) IRB: Ethics & Human Research 9-15

“How Can Journals Respond to Threats of Libel Litigation” (March 29, 2014). PLoS Medecine 11(3).  (with Nav Persaud and Thom Ringer) 

“Pharmaceutical Knowledge Governance: A Human Rights Perspective” (March 4, 2013). Journal of Law, Medicine and Ethics, Vol. 41(1), pp. 163-184, 2013.

“Introduction: Global Health Challenges and the Role of Law” (with Colleen Flood) (January 01, 2013). Journal of Law, Medicine and Ethics (Special Issue: Symposium: Global Health and the Law), Vol. 41, No. 1, 2013, 9-15. Colleen Flood and Trudo Lemmens, co-editors of the Special Issue.

“Analysis of Consent Validity For Invasive, Nondiagnostic Research Procedures” (with Jonathan Kimmelman & Scott Y.H. Kim) (2012) 34(5) IRB: Ethics and Human Research 1-7.

"Prospective registration and results disclosure of clinical trials in the Americas: a roadmap toward transparency" 30(1) Pan american Journal of Public Health (2011) 87-96. 

"Revisiting Genetic Discrimination Issues in 2010: Policy Options for Canada" peer reviewed Policy Brief, Genome Canada 2010. 

"Keeping the GINA in the Bottle: Assessing the Current Need for Genetic Non-Discrimination Legislation in Canada" (With Daryl Pullman) 4(2) Open Medicine (2010) 95-97.

"Governance of conflicts of interest in postmarketing surveillance research and the Canadian Drug Safety and Effectiveness Network" (With Lori Ferris) 4(2) Open Medicine 2010.

"The 7^th revision of the Declaration of Helsinki: good news for the transparency of clinical trials" (with Karmela Jeric) 50 Croatian Medical Journal (2009) 105-110.

"The FDA and the Declaration of Helsinki: A new rule seems to be more about imperialism than harmonisation" (with Michael Goodyear, Dominique Sprumont & Godrey Tangwa) 338 British Medical Journal (2009) 1157-1158.

“Data Collection From Legally Incompetent Subjects: A Paradigm Legal and Ethical Challenge fro Population Databases" (with Tom Archibald) Health Law Journal (2008) Special Edition (Visions) 145-192. 

“Research Ethics Recommendations for Whole-Genome Research: Consensus Statement” (with Timothy Caulfield, et al) (2008) 3 (e73) PLoS Biology 0430-0435.

"Privatizing Biomedical Research: A "Third Way"?" (with Ron Bouchard) (2008) 26 Nature Biotechnology 31-36.

“Commercialized Research and the Need for Regulatory Reform” (2007) 5(3) ICFAI Journal of Health Care Law 21 [invited reprint of chapter (see above)].

“The Declaration of Helsinki” (with M.D. Goodyear & K. Krlez-Jeric) (editorial) (2007) 335(7623) British Medical Journal 736.

"Regulating the Market in Human Research Participants" (with Paul B. Miller) (August 2006) 3(8) PLoS Medicine [Public Library of Science] e330: 1237. (download paper at PLoS Medicine)

"Should society allow research ethics boards to be run as for-profit enterprise" (with Ezekiel Emanuel & Carl Elliott) (2006) 3(7) PLoS Medicine e309: 0941. (download paper at PLoS Medicine)

"Research ethics boards: reply from Trudo Lemmens and Carl Elliott" (2006) 3(10) PloS Medicine e471 [letter to the editor].

"The Social and Cultural Shaping of Medical Evidence: Case studies from pharmaceutical research and obstetric science" (with R. Devries) (2006) 62 Social Science & Medicine 2646.

"Leopards in the Temple: Restoring Integrity to the Commercialized Research Scene" (2005) 32(4) Journal of Law, Medicine & Ethics 641. (pdf)

"Federal Regulation of REB Review of Clinical Trials: A Modest but Easy Step Towards an Accountable REB Review Structure in Canada" (2005) 13(2-3) Health Law Review 39 [Special Issue on Research Governance, M. McDonald, ed.].

"Can Insurance Law Accommodate the Uncertainty Associated with Preliminary Genetic Information?" (2004) 83 Canadian Bar Review 357.

"Confronting the Conflict of Interest Crisis in Medical Research" (2004) 23(4) Monash Bioethics Review 19.

"Piercing the Veil of Corporate Secrecy About Clinical Trials" (2004) 34(5) Hastings Center Report 14. (download at Ingenta Connect)

"Integrating Values in Risk Analysis of Biomedical Research: The Case for Regulatory and Law Reform" (with Duff R. Waring) (2004) 54(3) University of Toronto Law Journal 249.

"Research Ethics and the Role of the Professional Bodies" (with T. Caulfield, D. Kinsella & M. McDonald) (2004) 32(2) Journal of Law, Medicine & Ethics 365.

"CIOMS' Placebo Rule and the Promotion of Negligent Medical Practice" (with D. Sprumont, H. Nys, J. Singh & K.C. Glass) (2004) 11 European Journal of Health Law 153.

"Genetics and Life Insurance in Canada: Points to Consider" (with B.M. Knoppers, B. Godard et al.) supplement to "Physicians, genetics and life insurance"  (April 27, 2004) 170(9) Canadian Medical Association Journal.

"Genetics and Insurance Discrimination: Comparative Legislative, Regulatory and Policy Developments and Canadian Options" Special Edition: Precedent and Innovation: Health Law in the 21st Century, (2003) Health Law Journal 41 [Special Supplement].

"The Human Subjects Trade: Ethical and Legal Issues Surrounding Recruitment Incentives" (with P.B. Miller) (2003) 31 Journal of Law, Medicine & Ethics 398.

"Avoiding a Jekyll and Hyde Approach to the Ethics of Clinical Research and Practice" (with P.B. Miller) (2002) 2(2) American Journal of Bioethics 14.

"Canadian Law on Euthanasia: Contrasts and Comparisons" (with B.Dickens) (2001) 8 European Journal of Health Law 135.

"The Challenges of Regulating the Use of Genetic Information" (with L. Austin) 2001 2(3) ISUMA, Canadian Journal of Policy Research 26-37.

Also forthcoming in the EOLSS Encyclopedia of Life Support Systems

"Justice for the Professional Guinea Pig" (with C. Elliott) (2001) 1(2) American Journal of Bioethics 51.

Also excerpted in Ezekiel J. Emanuel, Robert A. Crouch, John D. Arras, Jonathan D. Moreno & Christine Grady, eds., Ethical and Regulatory Aspects of Clinical Research: Readings and Commentary (Baltimore, MD: Johns Hopkins University Press, 2003) 183.

"Non-Institutional Commercial Review Boards in North America: A Critical Appraisal and Comparison with IRBs" (with A. Thompson) (2001) 23(2) IRB: A Review of Human Subjects Research 1. (pdf)

"Ethics Review for Sale? Conflict of Interest and Commercial Research Ethics Review Boards" (with B. Freedman) (2000) 78(4) Milbank Quarterly 547 (with B. Freedman).

To be republished as chapter in book, see above; also excerpted in Ezekiel J. Emanuel, Robert A. Crouch, John D. Arras, Jonathan D. Moreno, & Christine Grady, eds., Ethical and Regulatory Aspects of Clinical Research: Readings and Commentary (Baltimore, MD: Johns Hopkins University Press, 2003) 429.

"A Comparative Analysis of Research Ethics Review Mechanisms and the ICH Good Clinical Practice Guideline" (with M. Hirtle & D. Sprumont) (2000) 7 European Journal of Health Law 265.

"Selective Justice, Genetic Discrimination and Insurance: Should We Single Out Genes in Our Laws?" (2000) 45 McGill Law Journal 347.

"In the Name of National Security: Lessons from the Final Report of the Advisory Committee on Human Radiation Experiments" (1999) 6 European Journal of Health Law 7.

"Guinea Pigs on the Payroll: The Ethics of Paying Healthy Subjects" (with C. Elliott) (1999) 7(1) Accountability in Research 3.

"Structuring the Review of Human Genetics Protocols, Part III: Gene Therapy Studies" (with K.C. Glass, C. Weijer, D. Cournoyer, R.M. Palmer, S.H. Shapiro & B. Freedman) (1999) 21(2) IRB, A Review of Human Subjects Research 1.

Excerpted in Ezekiel J. Emanuel, Robert A. Crouch, John D. Arras, Jonathan D. Moreno & Christine Grady, eds., Ethical and Regulatory Aspects of Clinical Research: Readings and Commentary (Baltimore, MD: Johns Hopkins University Press, 2003) 297.

"Conflict of Interest in Research, Education and Patient Care" (with P. Singer) (1998) 159(8) Canadian Medical Association Journal 960.

"Structuring the Review of Human Genetics Protocols, Part II: Diagnostic and Screening Studies" (with K.C. Glass, C. Weijer, R. Palmer & S.H. Shapiro) (1997) 19(3.4) IRB, A Review of Human Subjects Research 1. 

Excerpted in Ezekiel J. Emanuel, Robert A. Crouch, John D. Arras, Jonathan D. Moreno & Christine Grady, eds., Ethical and Regulatory Aspects of Clinical Research: Readings and Commentary (Baltimore, MD: Johns Hopkins University Press, 2003) 291.

"‘What about your genes?’ Ethical, Legal and Policy Dimensions of Genetics in the Workplace" (1997) 16(1) Politics and the Life Sciences 57.

"Structuring the Review of Human Genetics Protocols: Gene Localization and Identification Studies" (with K.C. Glass, C. Weijer, C. Palmour, R.A. Shapiro & K. Lebacqz) (1996) 18(4) IRB, A Review of Human Subjects Research 1.

Excerpted in Ezekiel J. Emanuel, Robert A. Crouch, John D. Arras, Jonathan D. Moreno & Christine Grady, eds., Ethical and Regulatory Aspects of Clinical Research: Readings and Commentary (Baltimore, MD: Johns Hopkins University Press, 2003) 185.

"Euthanasie en ‘het goede leven’" (with a commentary by P. Schotsmans) (1996) 6 Ethische Perspektieven 72. [author's translation into Dutch, with revisions, of "Euthanasia and the Good Life"]

"Euthanasia and the Good Life" (1995) 39(1) Perspectives in Biology and Medicine 15.

"Sports, Doping and Clashing Values" (1994-1995) 2(1) Pandektis: the International Sports Law Review 3. 

Also included in Proceedings of the 2nd International Congress on Sports Law, Olympia, 29-31 October 1993. Republished in 2000 as book chapter (see above).
 

Reports

Rapid Response Expert Advisory Group, Canadian Foundation for HealthCare Improvement, “Better Together: Re-Integration of Family Caregivers as Essential Partners in Care in a Time of Covid19” (Ottawa: Canadian Foundation for Health Care Improvement, 2020) 20 p.

Sonu K. Gaind, et al. “Canada at a Crossroads: Recommendations on Medical Assistance in Dying and Persons with a Mental Disorder: An Evidence-Based Critique of the Halifax Group IRPP Report (26 March 2020). (Toronto, Expert Advisory Group on Medical Assistance in Dying, 2020) 34 pp. https://www.eagmaid.org/report

The Expert Panel Working Group on Advance Requests for MAID, Council of Canadian Academies, The State of Knowledge on Advance Requests for Medical Assistance in Dying. (Ottawa, ON: Council of Canadian Academies, 2018) 219 pp. https://cca-reports.ca/wp-content/uploads/2019/02/The-State-of-Knowledge-on-Advance-Requests-for-Medical-Assistance-in-Dying.pdf.

Jordan Jarvis et al., “Re: Canada’s support to the World Health Assembly Resolution on improving the transparency of markets for drugs and health technologies.” Letter (sent by e-mail) to the Honourable Ginette Petitpas Taylor, Minister of Health (8 April 2019).

Trudo Lemmens, Kanksha Mahadevia Ghimire, Elizabeth Rafferty, et al. (Forthcoming 2019). Balancing the Privacy Right of Research Participants with the Public Interest in Access to Clinical Drug Trials Data. (Report, funded by Office of the Privacy Commissioner of Canada). (Toronto: University of Toronto, forthcoming 2019), online: https://library.law.utoronto.ca/privacy-access-drug-trials-data.   

Joel Lexchin et al., “Response to draft guidance document: public release of clinical information” (May 2018). Submission to Health Canada.

Joel Lexchin et al., “Responses to regulations amending the Food and Drug Regulations (Public Release of Information) (February 2018). Submission to Health Canada.

Rosario Cartagena, Alison Thompson, Kaveh Katebian, Trudo Lemmens et al., “Understanding the Relationship between Suffering and Capacity at the End-of-Life: A Pilot Study” (December 2016), 59 p.  Report commissioned by the Law Commission of Ontario as part of the project, Improving the Last Stages of Life, online: http://www.lco-cdo.org/wp-content/uploads/2010/10/Cartagena%20et%20al.pdf.

Trudo Lemmens, “Critical Reflections on Bill C-14 on Medical Assistance in Dying”. Submission to the Senate Standing Committee on Legal and Constitutional Affairs, Re Bill C-14, Medical Assistance in Dying.  28 April 2016.

Trudo Lemmens, “Strengthening Safeguards and Avoiding MAID Based on Advanced Directives” Submission to the House of Commons Standing Committee on Justice and Human Rights on Bill C-14, Medical Assistance in Dying, 28April 2016.

Trudo Lemmens, “Response to comments made during the Committee Hearing of January 28, 2016”, Submission to the Joint Parliamentary Committee on Physician-Assisted Dying, 2 February 2016.

Trudo Lemmens, “Why Canada Should Avoid a Belgian-Style Regulatory Regime for Physician Assisted Dying”, Submission to the Joint Parliamentary Committee on Physician-Assisted Dying, January 27, 2016.

The Expert Panel on Timely Access to Health and Social Data for Health Research and Health Systems Innovation, Accessing Health and Health-Related Data in Canada, (Ottawa: Council of Canadian Academies, 2015) 219 p., online: http://www.scienceadvice.ca/uploads/ENG/Assessments%20and%20Publications%20and%20News%20Releases/Health-data/HealthDataFullReportEn.pdf.

Trudo Lemmens, Thomas A. Ban and Louis C. Charland, Final Report of the Independent Inquiry into the University of Ottawa, the Institute of Mental Health Research and the Ottawa Hospital. Inquiry Conducted for the Canadian Association of University Teachers (March 2013), 81 pp., online: https://www.caut.ca/docs/default-source/reports/report-of-the-independent-committee-of-inquiry-into-the-university-of-ottawa-cimhr-and-roh.pdf?sfvrsn=0.

Dario Kuzmanovic, Nivedita Ravi and Trudo Lemmens, Management of Conflict of Interest in the Context of Research Ethics Review, Report submitted to the World Health Organization (2013), 28 pp.

Shannon Gibson & Trudo Lemmens, “Regulating Off-Label Prescribing: the Good, the Bad, and the Uncertain” (April 2013) Memorandum submitted to the Canadian Senate Standing Committee on Social Affairs, Science and Technology (April 2013), 10 pp.

Clinical Trials Advisory Group on Patient Confidentiality, “Final advice to the European Medicines Agency from the clinical trial advisory group on Protecting Patient Confidentiality” 30 April 2013, online: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2013/04/WC500142853.pdf(Member, Advisory Group)
Clinical Trials Advisory Group on Legal Aspects, “Final advice to the European Medicines Agency from the clinical trial advisory group on Legal Aspects” 30 April 2013, online: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2013/04/WC500142857.pdf (Member, Advisory Group).

Trudo Lemmens, “Promoting Transparency of Clinical Trials: How is Canada Doing?” Memorandum submitted to the Canadian Senate Standing Committee on Social Affairs, Science and Technology (May 2012), 9 pp.

Trudo Lemmens & Shannon Gibson, “The Case for Improved Post-Market Surveillance of Pharmaceuticals” Memorandum submitted to the Canadian Senate Standing Committee on Social Affairs, Science and Technology (December 2012), 8 pp.

Cancer Care Ontario, Mapping a Way Through the Double Helix: Making Sense of Personalized Medicine for Ontario’s Cancer System, Report of a Signature Event, December 8, 2010. Summary of Proceedings (Toronto: Cancer Care Ontario, 2010), 41 pp. (Contribution by sharing of lecture notes, slides and editing of section report).

Privacy and Access to Genetic Research Data: Workshop Report (with Ruth Vale and Ubaka Ogbogu). (Toronto, 2009). available at http://www.law.utoronto.ca/healthlaw/

Contactforum "Medische keuring bij private verzekeringen juridisch doorgelicht" (with H. Nys, H. Cousy & C. Van Schoubroeck, eds.) 22 Maart 2007 [Medical Testing for Private Insurance: a Legal Diagnosis] (Brussel: Royal Flemish Academy of Belgium for Science and the Arts, 2008).

Report of the Ethics Review Committee [regarding implementation of the 1998 Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans]  (as Chair, with Committee Members: Loren Falkenberg, Edith De Leury and Chantal Beauvais).  Submitted to CIHR, NSERC and SSHRC, December 20, 2002.

Legal and Ethical Challenges of New Predictive Genetic Testing (with Roxanne Mykitiuk as Co-Chairs, with Committee Members: M. Lacroix, L. Austing, and B. Amani). Report of the Legal and Ethical Subcommittee of the Ontario Expert Advisory Committee on New Predictive Genetic Technologies.

The Regulation and Organization of Research Ethics Review: Report of a Comparative International Workshop held at the Faculty of Law, University of Toronto, June 16-18, 2005. (by Angela Long, A. Sasha Kontic, Elizabeth Cuéllar Barroso and Daniel Brinza, ed. Trudo Lemmens and Tom Archibald. Toronto: Brown Book Company, 2006). 102 pp. Including 2 Wall Charts:
(1) Regulation and Organization of International Research Ethics Review - Various Countries.
(2) Regulation and Organization of International Research Ethics Review - Seven European Countries.

"After Capacity: The Legal and Ethical Problems of Data Collection from Legally Incompetent Subjects in Canada" (with T. Archibald). Report submitted to the Canadian Institutes for Health Research, 2007, 58 pp.

Genetic Information and the Law: Issues in the Insurance and Employment Settings: A report for the 4th Health Law Day held at the Faculty of Law, University of Toronto, May 20, 2005. [Toronto: Brown Book Company, 2006]

Genetic Services in Canada: Mapping the Future. Report of the Provincial Advisory Committee on New Predictive Genetic Technologies (Queen’s Printer for Ontario, 2001) 116 pp. (Member of the Committee)

"Volume, Depth and Speed: The Challenges of Genetic Information" (with L. Austin) discussion paper prepared for the Canadian Biotechnology Advisory Commission (2001), 40 pp.. (Shorter version published as an article)

Complementary/Alternative Health Care and HIV/AIDS: Legal, Ethical and Policy Issues in Regulation,  (with R. Crouch, R. Elliott & L. Charland). Report for the Canadian HIV/AIDS Legal Network (Montreal: Canadian HIV/AIDS Legal Network, 2001) 164 pp.. (Also available in French)
 
A Comparative Analysis of Research Ethics Review Mechanisms and the ICH Good Clinical Practice Guideline,  (with D. Sprumont & M. Hirtle). Report Submitted to the Council of Europe (1999) 41 pp. (Shorter version published as an article).

Genetics in Life, Disability and Additional Health Insurance in Canada: a Comparative Legal and Ethical Analysis,(with P. Bahamin). Report prepared for the Medical, Ethical, Legal and Social Issues Committee of the Canadian Genome Analysis and Technology Program (Montréal: Université de Montréal, Centre de Recherche en Droit Public, 1996) (revised version subsequently published as chapter -see above), 188 pp.

Évaluation éthico-juridique du projet de carte de santé de Rimouski, (with S. Lebris & B.M. Knoppers). Report prepared for the "Commission d'accès à l'Information du Québec" (1995) 60 pp..

Belgisch Vreemdelingenrecht 1990 [Belgian Law in relation to foreigners], Report for the European Commission, Leuven (1991) 60 pp.
 

Doctoral Thesis

Genetic Information and Insurance: A Contextual Analysis of Legal and Regulatory Means of Promoting Just Distributions, Doctor of Civil Law (D.C.L.) Institute of Comparative Law, McGill University, 2003.
 

Other Articles, Comments, Notes, Op-Ed

Trudo Lemmens, “Le protocol Québécois de triage clinique donne lieu à la discrimination” Options Politiques (June 15, 2020) https://policyoptions.irpp.org/fr/magazines/june-2020/le-protocole-quebecois-de-triage-clinique-donne-lieu-a-la-discrimination/ (translated by author in English:  Clinical Triage Protocol Opens Door to Discrimination” Policy Options (June 15, 2020) https://policyoptions.irpp.org/magazines/june-2020/quebecs-clinical-triage-protocol-opens-door-to-discrimination/ (originally written in French: )

Daren Heyland et al., “More than just visitors: A Canadian Declaration of Family Caregivers Rights and Responsibilities” (2020) https://www.caregivers4change.com/declarationfull  (contributor)

Roxanne Mykitiuk & Trudo Lemmens, “Assessing the value of a life: COVID-triage orders mustn’t work against those with disabilities” (19 April 2020) CBC Opinion, online: https://www.cbc.ca/news/opinion/opinion-disabled-covid-19-triage-orders-1.5532137. (Also published in The Hill Times.)

Trudo Lemmens, “Letter to the Editor re: ‘Legislators must stop dittering on MAID’ (18 February 2020)”, Globe and Mail (20 February 2020).

Trudo Lemmens, “Aide médicale à mourir: le Canada devrait tirer des leçons de l’expérience belge” (translation of Montreal Gazette article) (10 February 2020) La Presse, online: https://www.lapresse.ca/debats/opinions/202002/09/01-5260245-aide-medicale-a-mourir-le-canada-devrait-tirer-des-lecons-de-lexperience-belge.php.

Trudo Lemmens, “Opinion: Canada must learn lessons from Belgium on assisted dying” (29 January 2020) Montreal Gazette, online: https://montrealgazette.com/opinion/opinion-canada-must-learn-lessons-from-belgium-on-assisted-dying/. (Slightly longer version also published in Hamilton Spectator, Ottawa Life, Winnipeg Free Press, Winnipeg Sun, The Province, St.Catherines Standard, Welland Tribute, Niagara Falls Review, Peterborough Examiner, Vancouver Province.)

Translation of Janis Schaerlaeken, “The autism diagnosis saved my life” (19 January 2020), online: https://trudolemmens.wordpress.com/2020/01/19/being-diagnosed-with-autism-saved-my-life/.

Trudo Lemmens & Laverne Jacobs, “The latest medical assistance in dying decision needs to be appealed: Here’s why” (9 October 2019), The Conversation, online: https://theconversation.com/the-latest-medical-assistance-in-dying-decision-needs-to-be-appealed-heres-why-124955. (Also translated in French, https://theconversation.com/aide-medicale-a-mourir-voici-pourquoi-il-faut-aller-en-appel-125056).

Trudo Lemmens, Comment on Anonymous, “We risk our careers if we discuss assisted suicide, say UK palliative care consultants”, BMJ Opinion (21 March 2019), online: https://blogs.bmj.com/bmj/2019/03/21/we-risk-our-careers-if-we-discuss-assisted-dying-say-uk-palliative-care-consultants/.

Trudo Lemmens & Paul Thacker, “Time for Full Transparency on Pharmaceutical Data” Toronto Star (7 July 2017), online: https://www.thestar.com/opinion/commentary/2017/07/07/time-for-full-transparency-on-pharmaceutical-money.html.

Willem Lemmens, Trudo Lemmens & Arthur Caplan, “The Dangers of Euthanasia-on-Demand” (Editorial), Chicago Tribune (October 2016), online: https://www.chicagotribune.com/opinion/commentary/ct-euthanasia-assisted-suicide-dutch-netherlands-perspec-1018-jm-20161017-story.html.

Trudo Lemmens, “Letter re: “Limits on Assisted Suicide Unconstitutional, Lawyer says”, Toronto Star (12 May 2016), online: https://www.thestar.com/opinion/letters_to_the_editors/2016/05/12/bill-c-14s-constitutionality-backed.html.

Trudo Lemmens, Restoring the Integrity of the Pharmaceutical Science Record: Two Tales of Transparency, JOTWELL (14 July 2016) (reviewing Jon N. Jureidini, Jay D. Amsterdam & Leemon B. McHenry, The Citalopram CIT-MD-18 Pediatric Depression on Trial: Deconstruction of Medical Ghostwriting, Data Mischaracterisation and Academic Malfeasance, 28 Int’l J. Risk & Safety Med. 33 (2016); Joanna Le Noury et al., Restoring Study 329: Efficacy and Harms of Paroxetine and Imipramine in Treatment of Major Depression in Adolescence, 351 Brit. Med. J. 4320 (2015), online: https://health.jotwell.com/restoring-the-integrity-of-the-pharmaceutical-science-record-two-tales-of-transparency/.

Matthew Herder, Trudo Lemmens, Joel Lexchin, Barbara Mintzes & Tom Jefferson “Pharmaceutical transparency in Canada: tired of talk” BMJ Blog, June 6, 2016. http://blogs.bmj.com/bmj/2016/06/06/pharmaceutical-transparency-in-canada-tired-of-talk/ [slightly revised version also published in Policy Options: “Is Pharmaceutical Transparency in Canada Just Talk?” Policy Options (12 July 2016), online: https://policyoptions.irpp.org/magazines/july-2016/is-pharmaceutical-transparency-in-canada-all-just-talk/.

Trudo Lemmens, “Senator Murray Sinclair’s Call for Senatorial and Legal Restraint Should Inspire All of Us”, Faculty of Law Blog (6 June 2016), online: https://www.law.utoronto.ca/blog/faculty/senator-murray-sinclairs-call-senatorial-and-legal-restraint-lesson-all.

Trudo Lemmens, “New Bill Medical Assistance in Dying Balances Competing Charter Rights; Prior Review Still Needed”, Faculty of Law Blog (14 April 2016), online: http://www.law.utoronto.ca/blog/faculty/new-bill-medical-assistance-in-dying.

Trudo Lemmens, “Canadians Support a More Prudent Approach to Medical-Aid-in-Dying than Parliamentary Committee, and Rightly So”, Faculty of Law Blog (10 April 2016),  online: http://www.law.utoronto.ca/blog/faculty/canadians-appear-support-more-prudent-approach-medical-aid-in-dying-and-rightly-so.

Trudo Lemmens, “Joint Parliamentary Committee Assisted Dying Report Goes Beyond Scope, Ignores Evidence (reproduction of Globe and Mail op-ed with David Baker with additional commentary)”, Faculty of Law Blog (5 April 2016),  online: http://www.law.utoronto.ca/blog/faculty/joint-parliamentary-committee-assisted-dying-report-does-beyond-scope-ignores-evidence.

Trudo Lemmens, “Balancing Access to Physician Assisted Dying with Protecting the Vulnerable” Faculty of Law Blog (1 April 2016), online: http://www.law.utoronto.ca/blog/faculty/balancing-access-physician-assisted-dying-protecting-vulnerable.
Trudo Lemmens, “Re: Another politician with his head in the sand, Wheels March 19” Letter to the Editor, Toronto Star, Faculty of Law Blog (27 March 2016), online: http://www.thestar.com/opinion/letters_to_the_editors/2016/03/27/anti-cycling-screed-missed-the-mark.html.

Trudo Lemmens, “Dangers of a Lax Assisted Death Regime”, Impact Ethics Blog Dalhousie University (3 March 2016), online: https://impactethics.ca/2016/03/03/dangers-of-a-lax-assisted-death-regime/.

David Baker & Trudo Lemmens, “Assisted Dying Report Goes Beyond Scope, Ignores Evidence”, Op-ed Globe and Mail (27 February 2016), online: http://www.theglobeandmail.com/opinion/assisted-dying-report-goes-beyond-scope-ignores-evidence/article28939386/.

Harvey Schipper & Trudo Lemmens, Why We Must Move Cautiously on Doctor-assisted Dying” Op-ed Globe and Mail (11 January 2016), online: http://www.theglobeandmail.com/opinion/why-we-must-move-cautiously-on-doctor-assisted-dying/article28090946/.

Matthew Herder & Trudo Lemmens, “Diclectin Data: Testing Canada’s New Transparency Law”, British Medical Journal Blog (27 October 2015), online: http://blogs.bmj.com/bmj/2015/10/27/diclectin-data-testing-canadas-new-pharmaceutical-transparency-law/

Shannon Gibson & Trudo Lemmens, “The Promise and Peril of Adapting the Regulatoy System to the Pharmacogenomic Context: New Paper McGill Journal of Law & Health” University of Toronto Faculty of Law Blog (11 June 2015), online: http://www.law.utoronto.ca/blog/faculty/promise-and-peril-adapting-regulatory-system-pharmacogenomic-context-new-paper-gibson.

Trudo Lemmens, Raymond Devries, Lois Shepherd & Susan M. Reverby, “Minnesota Legislature Must Hold Hearing on Psychiatric Research Misconduct, Minnesota Post  (28 April 2015), online: https://www.minnpost.com/community-voices/2015/04/minnesota-legislature-must-hold-hearings-psychiatric-research-misconduct (also reposted on Faculty of Law Blog, 11 June 2015, online: http://www.law.utoronto.ca/blog/faculty/promise-and-peril-adapting-regulatory-system-pharmacogenomic-context-new-paper-gibson).

Trudo Lemmens, “The Pharmaceutical Industry’s Shift towards Niche Markets and ‘Personalized Medicine’: New Article Reports on Qualitative Study and Critically Analyzes Ethical and Regulatory Challenges,” University of Toronto Faculty of Law Blog (17 April  2015), online: https://www.law.utoronto.ca/blog/faculty/pharmaceutical-industry-s-shift-towards-niche-markets-and-personalized-medicine-new.

Trudo Lemmens, “Decreasing the Data Deficit: Improving Canada's Drug Regulatory System,” University of Toronto Faculty of Law Blog, April 15, 2015, online: https://www.law.utoronto.ca/blog/faculty/decreasing-data-deficit-improving-canadas-drug-regulatory-system.

Trudo Lemmens, “Paper Shannon Gibson & Trudo Lemmens on Pharmaceutical Innovation and Drug Regulatory Changes Available Online: Niche Markets and Evidence Assessment in Transition,” University of Toronto Faculty of Law Blog (16 December 2014), online: https://www.law.utoronto.ca/blog/faculty/new-paper-gibson-lemmens-pharmaceutical-innovation-and-drug-regulatory-changes-niche.

Trudo Lemmens, “EMA’s Proposed Data Release Policy: Promoting Transparency or Expanding Pharma Control over Data?” (guest blog), PLoS Speaking of Medicine, (30 May 2014), online: http://blogs.plos.org/speakingofmedicine/2014/05/30/emas-new-data-release-policy-promoting-transparency-expanding-pharma-control-data/.

Tom Jefferson, Peter Doshi & Trudo Lemmens, “EMA’s Data Sharing Policy--Towards Peeping Tom Medicine? BMJ Blog (22 May 2014), online:  http://blogs.bmj.com/bmj/2014/05/22/tom-jefferson-et-al-emas-data-sharing-policy-towards-peeping-tom-based-medicine/.

Trudo Lemmens, “Markingson Case Update: How an institution can transform a request for an ‘Independent Inquiry’ into another institutional procedural shield,” University of Toronto Faculty of Law Blog (24 April 2014), online: https://www.law.utoronto.ca/blog/faculty/markingson-case-update-how-institution-can-transform-request-independent-inquiry.

Trudo Lemmens, “Hyping Mass Vaccinations”, Letter to the Editor, Edmonton Journal, 6 January 2014, online: http://www.edmontonjournal.com/health/More+letters+Massive+farms+major+environmental+damage/9356019/story.html).

Trudo Lemmens, “Markingson Case: University of Minnesota sets up Inquiry, but will it be independent? And what will it do?” University of Toronto Faculty of Law Blog (19 December 2013), online: https://www.law.utoronto.ca/blog/faculty/markingson-case-university-minnesota-sets-independent-inquiry-what-will-it-do.

Trudo Lemmens, “University of Minnesota Should Investigate Suicide in Clinical Trial, Scholars Argue” Blog Post, University of Toronto Faculty of Law Blog (24 October 2013),  online: https://www.law.utoronto.ca/blog/faculty/university-minnesota-should-investigate-suicide-in-clinical-trial-scholars-argue.

Trudo Lemmens & Shannon Gibson, “Comparative Table: Overview of ‘reviews’ of the Markingson Case, 14 November 2013, 7 pp., online: http://www.law.utoronto.ca/utfl_file/count/users/lemmenst/Markingson%20FINAL2%20Nov%2014.pdf) (attachment to November 13 letter re Markingson case).

Trudo Lemmens, Raymond Devries, Alice Dreger, Lois Shepherd, Susan Reverby, Jerome Kassirer, Letter to President Kaler, Professor Von Dassow, and Senators of the University of Minnesota, 21 October 2013. (and follow-up letters re Markingson case, 13 November and 11 December 2013).

Trudo Lemmens “Individual Researcher Conflict of Interest in Biomedical Research: What Can Be Done About It?” (2013) 1 Deontologie/Tuchtrecht 51-61 (slightly revised version of online chapter for teaching manual College of Physicians and Surgeons of Canada (see above).

Trudo Lemmens, Letter re Health Canada Interview on Clinical Trials Data, Macleansonline, Science-ish (5 November 2012), online: http://www2.macleans.ca/2012/11/05/why-is-canada-such-a-laggard-on-clinical-trials-regulation/).

Trudo Lemmens “Anglophone Media Using Protest to Attack All Things Quebec” blog, Huffington Post Canada (31 May 2012), online: http://www.huffingtonpost.ca/trudo-lemmens/quebec-protest-coverage_b_1559079.html.

Simon Stern & Trudo Lemmens, “Opinion: Ghost Writing is Fraudulent”, The Scientist, 2 December 2011, online: http://www.the-scientist.com/?articles.view/articleNo/31347/title/Opinion--Ghost-Writing-is-Fraudulent/).

Trudo Lemmens & Simon Stern, Letter to the Editor, Globe and Mail (6 August 2011).

Trudo Lemmens, “The Assisted Human Reproduction Act and the Supreme Court of Canada”, Guestblog for TVO The Agenda (4 November 2011), online: http://theagenda.tvo.org/blog/agenda-blogs/guest-blog-assisted-human-reproduction-act-and-supreme-court-canada).

"Is Privacy Really at the Heart of the Mandatory Census Change" (Opinion) The Hill Times August 23, 2010) p.7 (also repreoduced in the University of Toronto, Faculty of Law Blog).

"Is there a Lack of Ethical Integrity in Drug Trials?" (2010) (book review of Jill A. Fisher, Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials) 29(10) Health Affairs 1966-1967. 

"Revisiting Genetic Discrimination Issues in 2010: Policy Options for Canada (Policy Brief No. 2)" (with Daryl Pullman & Rebecca Rodal) (2010) Genome Canada, available at http://ssrn.com/abstract=1722368

"Ethics For Sale: For-profit ethical review, coming to a clinical trial near you." (with Carl Elliott) (2005) Slate (on-line periodical) December 13, 2005, available at http://www.slate.com/id/2132187/

"Genetics and life insurance : A Comparative Analysis" (with Y. Joly & B.M. Knoppers)  2(2) GenEdit (on-line publication, available at http://www.humgen.umontreal.ca/en/GenEdit.cfm) 15 pp.

"Why regulate new genetics" Innovate (Spring 2004), 14-17

"Why regulate the new genetics?"  (2003) 83 Reform: A Journal of National and International Law Reform 41.

"Préface" in G. Cardinal, Les dimensions normatives de la thérapie génique (Montréal: Les Éditions Thémis, 2003) XI-XIII.

"Moral Duty But Also Self-Interest Requires A Greater Commitment To the South" (with J. Singh) (2003) 8(2) Canadian Bioethics Society Newsletter 5-7.

 "SARS is bad, malaria is worse," National Post, May 2, 2003, third in a series of articles by U of T law school faculty members written in conjunction with the conference "Anatomy of a Crisis: Law & Policy Responses to SARS."

"Regulating the Trade in Human Research Subjects," Nexus (Fall/Winter 2002) 25-27.

"Finder's Fees and Therapeutic Obligations" (with P.B. Miller) (2002) 5(1) Geriatrics and Aging 66-69.

 "Reading the Book of Life: now that we have a partial script for human genes, who should read it--and how should it be sold?" University of Toronto Bulletin (February 26, 2001): 16.

 "Impact of Legalization" in "Pro and Contra. A Time to Die: Is there a Place in Medicine for Euthanasia?" (2001) 9(3) Parkhurst Exchange 25.

"Balancing Ethical Research Issues in Psychiatry" (with P.B. Miller) (2000) 17(6) Psychiatric Times 63-67.

"Placebo-controlled studies in schizophrenia: ethical and scientific perspectives. Panel discussion" (I chaired the panel, with presenters P.S. Appelbaum, W. Carpenter, C. McCarthy, C. Peterson, D. Streiner & C. Weijer). (1999) 35 Schizophrenia Research 227-236.

"Genetic Testing: A Profile" Unum Advisor (Winter 1998): 1-3. 

"Benjamin Freedman: A Life of Commitment." (1997) 8(1) National Council on Bioethics in Human Research Communiqué 6-7.

"A Response to the Parliamentary Sub-Committee's Report and Recommendations on Compassionate Access to Experimental Drugs of the Parliamentary Subcommittee on HIV/AIDS." (1997) 3(2-3) Canadian HIV/AIDS Policy and Law Newsletter 40-43.

"Compassionate Access to Experimental Drugs" (1996) 3(1) Canadian HIV/AIDS Policy and Law Newsletter 41-44.

"US Appeal Courts Rule in Favour of Assisted Suicide" (case comment) (1996) 2(4) Canadian HIV/AIDS Policy and Law Newsletter 1, 42-43.

"Legalizing Euthanasia" (1995) 2(1) Canadian HIV/AIDS Policy and Law Newsletter 7-9.

"Oregon's Measure 16 Declared Unconstitutional" (1995) 2(1) Canadian HIV/AIDS Policy and Law Newsletter 10.

"Bank's Drug Testing Program: Not Discriminatory, but Intrusive" (case comment) (1995) 1(2) Canadian HIV/AIDS Policy and Law Newsletter 4-5.

"L'utilisation de l'information génétique par les compagnies d'assurances" L'Actualité Médicale, 29 September 1993: 42-43.

Back to Top